Cargando…
Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells
BACKGROUND: Bone morphogenetic proteins (BMP) are evolutionarily conserved morphogens that are reactivated in lung carcinomas. In lung cancer cells, BMP signaling suppresses AMP activated kinase (AMPK) by inhibiting LKB1. AMPK is activated by mitochondrial stress that inhibits ATP production, which...
Autores principales: | Mondal, Arindam, Roberge, Jacques, Gilleran, John, Peng, Youyi, Jia, Dongxuan, Akel, Moumen, Patel, Yash, Zoltowski, Harrison, Doraiswamy, Anupama, Langenfeld, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238106/ https://www.ncbi.nlm.nih.gov/pubmed/35761398 http://dx.doi.org/10.1186/s12964-022-00905-4 |
Ejemplares similares
-
Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans
por: Vora, Mehul, et al.
Publicado: (2022) -
Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2022) -
Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells
por: Mondal, Arindam, et al.
Publicado: (2021) -
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein
por: NeMoyer, Rachel, et al.
Publicado: (2019) -
Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines
por: Langenfeld, Elaine, et al.
Publicado: (2013)